Insys therapeutics, inc. (INSY)
Income statement / TTM
Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12
Net revenue

65,799

82,080

96,393

120,623

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net revenue

-

-

-

-

-

-

-

-

217,816

-

281,329

312,073

323,052

330,323

299,888

269,652

245,148

219,092

195,811

166,741

129,866

99,289

0

0

0

-

-

-

-

Net revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Cost of revenue

13,174

10,803

12,790

17,883

18,208

20,643

25,837

23,042

25,394

25,393

22,055

25,085

27,117

28,854

28,247

25,930

24,180

22,578

21,929

19,635

15,674

12,665

9,514

8,366

8,113

7,627

0

0

0

Gross profit

52,625

71,277

84,418

91,649

110,434

120,050

138,231

168,129

192,422

216,882

259,274

286,988

295,935

301,469

271,641

243,722

220,968

196,514

173,882

147,106

114,192

86,624

54,736

31,425

16,396

7,849

0

0

0

Operating expenses:
Sales and marketing

26,440

31,372

32,583

38,050

42,263

48,870

55,273

59,110

65,509

69,651

74,702

77,257

79,552

80,668

79,468

75,312

67,403

58,105

51,227

44,135

36,389

29,194

21,903

16,833

13,430

11,411

0

0

0

Research and development

55,835

57,572

59,581

64,650

62,280

62,954

62,062

59,026

67,812

73,913

74,501

70,307

65,214

56,781

53,641

48,337

39,730

33,136

23,366

18,085

10,817

8,499

6,006

5,388

5,163

6,305

0

0

0

General and administrative

40,702

39,268

38,825

41,229

40,997

46,487

32,818

39,161

42,442

42,098

68,113

63,040

64,400

62,948

55,346

53,556

48,961

44,283

36,996

30,480

22,578

16,372

12,002

9,995

9,053

8,170

0

0

0

Legal

69,351

54,011

41,898

32,372

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Charges related to litigation award and settlements

89,900

16,777

151,620

156,040

0

-

0

0

-

-

-

-

-

10,616

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

Total operating expenses

282,228

199,000

183,836

335,991

337,387

339,081

340,234

192,124

199,657

209,556

217,316

210,916

211,782

211,013

199,071

187,509

164,094

135,524

111,589

92,700

69,784

54,065

45,314

37,619

33,049

31,289

0

0

0

Operating loss

-229,603

-127,723

-99,418

-244,342

-226,953

-219,031

-202,003

-23,995

-7,235

7,326

41,958

76,072

84,153

90,456

72,570

56,213

56,874

60,990

62,293

54,406

44,408

32,559

9,422

-6,194

-16,653

-23,440

0

0

0

Other income (expense):
Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,318

2,719

2,684

0

0

0

Interest income

1,904

1,984

1,941

1,968

1,949

1,881

1,687

1,458

1,249

1,039

906

753

602

502

434

349

270

151

83

0

0

-

0

-

-

-

-

-

-

Other expense, net

-1,107

-668

-473

-556

-540

-45

-29

54

36

59

7

37

0

-

0

0

-

2

-19

-43

-37

-54

2,320

2,254

1,824

1,746

0

0

0

Total other income (expense)

797

1,316

1,468

1,412

1,409

1,836

1,658

1,512

1,285

1,098

993

803

687

538

416

368

259

153

65

6

-286

-982

0

0

0

-

-

-

-

Loss before income taxes

-228,806

-126,407

-97,950

-242,930

-225,544

-217,195

-200,345

-22,483

-5,950

8,424

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income (loss) before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

62,358

54,412

44,122

31,577

10,111

-6,258

-17,548

-24,378

0

0

0

Income tax expense

-825

-1,900

26,111

16,917

15,137

9,640

-15,705

-7,048

-4,726

834

13,566

25,785

30,364

32,941

25,650

22,370

22,870

25,089

9,630

1,602

-3,770

-8,800

907

375

0

0

0

0

0

Net loss

-227,981

-124,507

-124,061

-259,847

-240,681

-226,835

-184,640

-15,435

-1,224

7,590

29,385

51,090

54,476

58,053

47,336

34,211

34,263

36,054

52,728

52,810

47,892

40,377

9,204

-6,633

-17,548

-24,378

0

0

0

Unrealized gain (loss) on available-for-sale securities, net of tax of $27 and $0

374

169

-111

-187

-323

-136

-164

-335

-241

-150

-107

101

10

-128

53

-12

22

-24

0

0

0

-

-

-

-

-

-

-

-

Total comprehensive loss

-227,607

-124,338

-124,172

-260,034

-241,004

-226,971

-184,804

-15,770

-1,465

7,440

29,278

51,191

54,486

57,925

47,389

34,199

34,285

36,030

52,708

52,805

47,874

40,377

0

0

0

-

-

-

-

Net loss per common share:
Net income (loss) allocable to preferred stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net income (loss) allocable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Basic

-1.66

-0.62

-0.41

-0.37

-0.28

-0.64

-2.28

-0.11

-0.09

-0.04

0.04

0.08

0.03

0.26

0.34

0.13

0.08

-0.02

0.17

0.14

0.23

0.23

0.36

0.18

0.01

-0.76

-0.46

-0.68

-0.72

Diluted

-1.66

-0.62

-0.41

-0.37

-0.28

-0.64

-2.28

-0.11

-0.09

-0.05

0.04

0.08

0.03

0.25

0.32

0.12

0.08

-0.01

0.16

0.13

0.21

0.18

0.34

0.17

0.01

-0.76

-0.46

-0.68

-0.72

Weighted average common shares outstanding
Basic

74,426

74,374

74,254

73,920

73,745

73,621

72,810

72,169

71,945

71,782

71,640

71,543

71,592

72,030

71,905

71,517

70,916

103,639

69,233

68,596

33,566

136,201

32,107

24,972

14,077

17,848

9,314

9,314

786

Diluted

74,426

74,374

74,254

73,920

73,745

73,621

72,810

72,169

71,945

73,822

74,328

74,053

74,462

76,442

75,991

75,478

74,918

110,635

73,128

72,673

36,902

153,935

34,183

26,058

15,700

17,848

9,314

9,314

786